Acadian Asset Management
FLNA

Acadian Asset Management’s Filana Therapeutics FLNA Stock Holding History

Acadian Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478K Hold
284,213
– – ﹤0.01% 1368
2025
Q4 		$561K Buy
284,213
+259,774
+1,063% +$832K ﹤0.01% 1275
2025
Q3 		$71K Buy
+24,439
New +$56.2K ﹤0.01% 1589
2024
Q4 		– Sell
-1,746
Closed -$51K – 2093
2024
Q3 		$51K Buy
+1,746
New +$40.2K ﹤0.01% 1785
2020
Q1 		– Sell
-15,207
Closed -$79K – 1922
2019
Q4 		$79K Buy
+15,207
New +$26.3K ﹤0.01% 1530
2019
Q2 		– Sell
-39,919
Closed -$51K – 2011
2019
Q1 		$51K Buy
39,919
+16,487
+70% +$18.9K ﹤0.01% 1670
2018
Q4 		$20K Buy
+23,432
New +$26.9K ﹤0.01% 1558
2017
Q3 		– Sell
-581
Closed -$2K – 1521
2017
Q2 		$2K Buy
+581
New +$2.74K ﹤0.01% 1403
2017
Q1 		– Sell
-4,867
Closed -$19K – 1742
2016
Q4 		$19K Sell
4,867
-58,480
-92% -$271K ﹤0.01% 1322
2016
Q3 		$444K Buy
63,347
+13,194
+26% +$219K ﹤0.01% 835
2016
Q2 		$769K Buy
50,153
+353
+0.7% +$5.6K ﹤0.01% 679
2016
Q1 		$777K Sell
49,800
-419
-0.8% -$5.42K ﹤0.01% 670
2015
Q4 		$615K Sell
50,219
-445
-0.9% -$5.89K ﹤0.01% 776
2015
Q3 		$649K Sell
50,664
-964
-2% -$12.2K ﹤0.01% 740
2015
Q2 		$625K Sell
51,628
-39,494
-43% -$541K ﹤0.01% 760
2015
Q1 		$1.21M Sell
91,122
-8,628
-9% -$116K 0.01% 627
2014
Q4 		$1.42M Sell
99,750
-8,844
-8% -$153K 0.01% 567
2014
Q3 		$2.98M Buy
108,594
+15,277
+16% +$464K 0.01% 431
2014
Q2 		$3.75M Buy
93,317
+74,647
+400% +$2.76M 0.02% 422
2014
Q1 		$720K Buy
+18,670
New +$659K ﹤0.01% 620

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Acadian Asset Management's FLNA Position: Q1 2026 in Review

Acadian Asset Management held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 284,213 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

Acadian Asset Management first reported a position in FLNA in Q1 2014 and has held it in 20 quarters since. The position peaked at $3.75M in Q2 2014. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Acadian Asset Management held 284,213 shares of Filana Therapeutics worth $478K as of Q1 2026.
  • Acadian Asset Management left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1368 holding.
  • Acadian Asset Management first reported a position in Filana Therapeutics in Q1 2014 and has held it in 20 quarters since.
  • Acadian Asset Management's Filana Therapeutics position peaked at $3.75M in Q2 2014.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.